# Endotronix to build new expanded headquarters and manufacturing facility in Naperville

Endotronix signed a lease for an 80,000+ sq ft facility in Naperville, Illinois, to serve as its new U.S. headquarters with a state-of-the-art manufacturing facility. The company plans a 30% workforce expansion to support the commercial launch of its Cordella Heart Failure System.

- Type: Expansion
- Announced: 2022-07-19
- Where: Naperville, Illinois, United States
- Jobs: 30
- Starts operating: Q1 2023
- Status: under construction
- Capacity: 80,000+ sq ft
- Products: Cordella Heart Failure System, Pulmonary Artery Sensor
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Endotronix](https://endata.com/companies/64246.md)

## Sources

- [prnewswire.com](https://www.prnewswire.com/news-releases/endotronix-announces-development-agreement-for-a-new-expanded-us-headquarters-in-naperville-illinois-301588407.html), 2022-07-19: "This is an exciting time for Endotronix."
- [choosedupage.com](https://www.choosedupage.com/business-climate/endotronix-announces-expansion-of-u-s-headquarters-in-naperville-illinois/), 2022-08-01: "This is an exciting time for Endotronix. As we approach full enrollment in our PROACTIVE-HF clinical trial, we are looking ahead toward scaling our manufacturing and operations in anticipation of commercialization of our proactive digital heart failure system."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.